Inventor · disambiguated record
Pierre Charneau
Also filed as: CHARNEAU PIERRE · CHARNEAU PIERRE ALAIN
35 granted patents·18 pending applications·518 citations·filing 1995–2023
97Inventor score
Top patents by PatentIndex Score
53 records- 0197US6682907B1Use of triplex structure DNA in transferring nucleotide sequencesPASTEUR INSTITUT·Filed 2000·Granted Jan 27, 2004·198 cites·41 claims
- 0293US8420104B2Lentiviral gene transfer vectors and their medicinal applicationsCHARNEAU PIERRE·Filed 2008·Granted Apr 16, 2013·43 cites·40 claims
- 0392US8709799B2Lentiviral gene transfer vectors and their medicinal applicationsCHARNEAU PIERRE·Filed 2012·Granted Apr 29, 2014·27 cites·22 claims
- 0492US8093042B2Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNACHARNEAU PIERRE·Filed 2005·Granted Jan 10, 2012·26 cites·62 claims
- 0591US10407695B2Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNAPASTEUR INSTITUT·Filed 2015·Granted Sep 10, 2019·13 cites·10 claims
- 0691US8349606B2Lentiviral vectors for the preparation of immunotherapeutical compositionsPASTEUR INSTITUT·Filed 2011·Granted Jan 8, 2013·10 cites·20 claims
- 0791US7981671B2Use of triplex structure DNA in transferring nucleotide sequencesPASTEUR INSTITUT·Filed 2008·Granted Jul 19, 2011·12 cites·24 claims
- 0890US8586364B2Cells and methodology to generate non-segmented negative-strand RNA virusesTANGY FREDERIC·Filed 2007·Granted Nov 19, 2013·12 cites·16 claims
- 0990US8343718B2Strain of SARS-associated coronavirus and applications thereofPASTEUR INSTITUT·Filed 2010·Granted Jan 1, 2013·22 cites·8 claims
- 1089US8367068B2Use of triplex structure DNA in transferring nucleotide sequencesPASTEUR INSTITUT·Filed 2010·Granted Feb 5, 2013·5 cites·26 claims
- 1188US8460678B2Use of triplex structure DNA in transferring nucleotide sequencesCHARNEAU PIERRE·Filed 2011·Granted Jun 11, 2013·5 cites·14 claims
- 1287US7968332B2Lentiviral vectors for the preparation of immunotherapeutical compositionsPASTEUR INSTITUT·Filed 2002·Granted Jun 28, 2011·16 cites·23 claims
- 1386US8450087B2Use of triplex structure DNA in transferring nucleotide sequencesCHARNEAU PIERRE·Filed 2011·Granted May 28, 2013·4 cites·20 claims
- 1482US8652807B2Lentiviral vectors for the preparation of immunotherapeutical compositionsPASTEUR INSTITUT·Filed 2012·Granted Feb 18, 2014·4 cites·25 claims
- 1581US8512993B2Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNACHARNEAU PIERRE·Filed 2011·Granted Aug 20, 2013·4 cites·20 claims
- 1681US7736850B2Strain of SARS-associated coronavirus and applications thereofPASTEUR INSTITUT·Filed 2004·Granted Jun 15, 2010·18 cites·5 claims
- 1779US8512994B2Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNACHARNEAU PIERRE·Filed 2011·Granted Aug 20, 2013·3 cites·18 claims
- 1878US8236324B2Nucleotide sequences of HIV-1 group (or subgroup) O retroviral antigensCHARNEAU PIERRE·Filed 2006·Granted Aug 7, 2012·2 cites·11 claims
- 1976US9238824B2Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNAPASTEUR INSTITUT·Filed 2013·Granted Jan 19, 2016·2 cites·20 claims
- 2076US6103462ARapid single-cycle assay for human immunodeficiency virus type-1 drug resistancePASTEUR INSTITUT·Filed 1998·Granted Aug 15, 2000·56 cites·18 claims
- 2175US8222029B2Lentiviral vector-based vaccineCHARNEAU PIERRE·Filed 2006·Granted Jul 17, 2012·1 cites·22 claims
- 2275US8158413B2Lentiviral vector-based vaccineCHARNEAU PIERRE·Filed 2005·Granted Apr 17, 2012·1 cites·22 claims
- 2374US9328146B2Lentiviral gene transfer vectors and their medicinal applicationsPASTEUR INSTITUT·Filed 2014·Granted May 3, 2016·2 cites·22 claims
- 2470US9442114B2Isolated and purified strains of Chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereofPASTEUR INSTITUT·Filed 2014·Granted Sep 13, 2016·2 cites·17 claims
- 2567US6558923B2Rapid single-cycle assay for human immunodeficiency virus type 1 drug resistancePASTEUR INSTITUT·Filed 2001·Granted May 6, 2003·3 cites·18 claims
- 2667US6399294B1Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigensPASTEUR INSTITUT·Filed 1995·Granted Jun 4, 2002·17 cites·11 claims
- 2763US2006040347A1Use of triplex structure DNA in transferring nucleotide sequencesCHARNEAU PIERRE·Filed 2003·Application pending·0 cites
- 2863US2019119699A1Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dnaPASTEUR INSTITUT·Filed 2018·Application pending·0 cites
- 2963US2018346928A1Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dnaPASTEUR INSTITUT·Filed 2018·Application pending·0 cites
- 3060US2025090655A1Boosting sars-cov-2 immunity with a lentiviral-based nasal vaccinePASTEUR INSTITUT·Filed 2023·Application pending·0 cites
- 3159US2025073332A1Lentiviral vector, lentiviral particle for treating hepatitis b and its preparation method and application thereofTHERAVECTYS·Filed 2022·Application pending·0 cites
- 3258US11779640B2Lentiviral vector-based Japanese encephalitis immunogenic compositionPASTEUR INSTITUT·Filed 2020·Granted Oct 10, 2023·0 cites·17 claims
- 3357US2024415951A1Lentiviral vector for expression of human papillomavirus (hpv) antigens and its implementation in the treatment of hpv induced cancersTHERAVECTYS·Filed 2022·Application pending·0 cites
- 3456US9499799B2Cells and methodology to generate non-segmented negative-strand RNA virusesPASTEUR INSTITUT·Filed 2013·Granted Nov 22, 2016·0 cites·22 claims
- 3556US9109234B2Lentiviral vector based immunological compounds against malariaCHARNEAU PIERRE·Filed 2011·Granted Aug 18, 2015·0 cites·15 claims
- 3655US2005074876A1Bipotential liver cell lines from wild-type mammalian liver tissueINST NAT SANTE RECH MED·Filed 2003·Application pending·0 cites
- 3755US2008102057A1Bipotential liver cell lines from wild-type mammalian liver tissueINST NAT SANTE RECH MED·Filed 2008·Application pending·0 cites
- 3854US8716013B2Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccineDESPRES PHILIPPE·Filed 2011·Granted May 6, 2014·0 cites·14 claims
- 3954US7157225B2Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigensPASTEUR INSTITUT·Filed 2001·Granted Jan 2, 2007·10 cites·3 claims
- 4054US2024053339A1High throughput methods and products for sars-cov-2 sero-neutralization assayTHERAVECTYS·Filed 2021·Application pending·0 cites
- 4154US2025319173A1Lentiviral vectors targeting antigens to mhc-ii pathway and inducing protective cd8+ and cd4+ t-cell immunity in a hostPASTEUR INSTITUT·Filed 2022·Application pending·0 cites
- 4251US10603374B2Lentiviral vector-based Japanese encephalitis immunogenic compositionPASTEUR INSTITUT·Filed 2015·Granted Mar 31, 2020·0 cites·19 claims
- 4350US2023364216A1Lentiviral vectors enabling routing antigens to mhc-ii pathway and inducing cd4+ and cd8+ t-cell responses in a hostPASTEUR INSTITUT·Filed 2021·Application pending·0 cites
- 4449US2023256084A1Sars-cov-2 immunogenic compositions, vaccines, and methodsPASTEUR INSTITUT·Filed 2021·Application pending·0 cites
- 4549US2009214589A1Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccineDESPRES PHILIPPE·Filed 2005·Application pending·0 cites
- 4648US9822153B2Lentiviral vector based immunological compounds against malariaCHARNEAU PIERRE·Filed 2015·Granted Nov 21, 2017·0 cites·17 claims
- 4748US9752160B2Use of non-subtype B gag proteins for lentiviral packagingTHERAVECTYS·Filed 2012·Granted Sep 5, 2017·0 cites·13 claims
- 4847US2017362607A1Use of non-subtype b gag proteins for lentiviral packagingTHERAVECTYS·Filed 2017·Application pending·0 cites
- 4946US2012082693A1Use of proteins and peptides encoded by the genome of a novel sars-associated coronavirus strainVAN DER WERF SYLVIE·Filed 2011·Application pending·0 cites
- 5045US2003194392A1Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNAFiled 2002·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Pierre Charneau files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →